
CAS 915038-27-6
:Ordinare per
Purezza (%)
0
100
|
0
|
50
|
90
|
95
|
100
5 prodotti.
Obeticholic Acid Impurity 2
CAS:Formula:C26H44O4Colore e forma:White To Off-White SolidPeso molecolare:420.63Ref: 4Z-O-056003
5mgPrezzo su richiesta10mg1.456,00€25mg2.670,00€50mg4.368,00€100mgPrezzo su richiestaObeticholic Acid-d7 (mixture of stereoisomers)
CAS:Prodotto controllatoApplications 6-epi-Obeticholic Acid-d7 is an intermediate used in the synthesis of 6-Ethylchenodeoxycholic-d5 Acid (E899812), which is an isotope labelled compound of 6-Ethylchenodeoxycholic Acid (E899810), which is used in the investigative treatment of primary biliary cholangitis. Primary biliary cholangitis is an autoimmune disease of the liver that slowly progresses to cirrhosis.
References Ali, A. H, et al.: Expert Opin. Orphan Drugs, 4, 1011 (2016)Formula:C26D7H37O4Colore e forma:WhitePeso molecolare:427.6686-epi-Obeticholic Acid
CAS:Prodotto controllatoFormula:C26H44O4Colore e forma:NeatPeso molecolare:420.625(3a,5b,6b,7a)-6-Ethyl-3,7-dihydroxycholan-24-oic acid
CAS:Prodotto controllato(3a,5b,6b,7a)-6-Ethyl-3,7-dihydroxycholan-24-oic acid is a synthetic cholestane derivative that has been shown to be useful in the treatment of biliary cirrhosis. The synthesis of this compound involves the reduction of an ethyl ester using a grignard reagent followed by UV irradiation. The reaction yield is high with a large excess of Grignard reagent used. This compound has been shown to be active against hepatic bile ducts and liver cells in vitro. It also has anti-inflammatory effects and can be used as an alternative treatment for patients who are intolerant to ursodeoxycholic acid or chenodeoxycholic acid.Formula:C26H44O4Purezza:Min. 95%Colore e forma:SolidPeso molecolare:420.63 g/molRef: ST-EA-CP-O39013
10mgPrezzo su richiesta25mgPrezzo su richiesta50mgPrezzo su richiesta100mgPrezzo su richiesta



